Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review

Abstract When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.

Bibliographic Details
Main Authors: Fateen Ata, Safna Farsana Akkam Veettil, Mohammed Gaber, Nabil E. Omar, Ammar Madani, Hebatalla Mah. Afifi, Meeloud M. Aldardouri, Aliaa Amer, Samah Kohla, Abdul Rehman Zar Gul
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.3860